NA

Namita Agarwal

Active Director Designated Partner DIN 08771074
DIN 08771074 First appointment Jun 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Namita Agarwal

Data last updated:

Namita Agarwal is a Designated Partner at Meptron Pharmaceuticals Llp (since 2020). The company operates in Business Services.

DIN 08771074
Primary Designation Designated Partner
Industry Business Services
First Appointment 23 Jun 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Jun 20202020Active

Board colleagues of Namita Agarwal

NameDINCompanyDesignation
Vijay Agarwal08771073Meptron Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Meptron Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Namita Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Namita Agarwal

Namita Agarwal currently holds 1 directorship: Meptron Pharmaceuticals Llp (Designated Partner, since 23 Jun 2020).

Namita Agarwal was first appointed on 23 Jun 2020 as Designated Partner at Meptron Pharmaceuticals Llp.

The current boards of Namita Agarwal's companies include Vijay Agarwal (Meptron Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available